Synapse Open Synapse
Biology

STAT+: Helus’ psychedelic drug improved depression in study but faces safety questions

STAT News · · 1 min read

A psychedelic drug from Helus Pharma improved depression in a study, but is facing safety questions with a number of serious adverse events reported.

Latest from STAT News